Sulfamethoxazole/trimethoprim resistance overcall by VITEK® 2 and BD Phoenix™ in community-associated MRSA and MSSA

Journal article

Peer reviewed

G.W. Coombs, S. Mowlaboccus, D. Daley, T. Lee, J. Pearson, S. Pang and J.O. Robinson

Journal of Antimicrobial Chemotherapy, Vol.74(12), pp.3639-3641

2019

Files and links (1)

url

Link to Published Version *Subscription may be requiredView

Letter to the Editor

Title: Sulfamethoxazole/trimethoprim resistance overcall by VITEK® 2 and BD Phoenix™ in community-associated MRSA and MSSA
Authors/Creators: G.W. Coombs (Author/Creator)
S. Mowlaboccus (Author/Creator)
D. Daley (Author/Creator)
T. Lee (Author/Creator)
J. Pearson (Author/Creator)
S. Pang (Author/Creator)
J.O. Robinson (Author/Creator)
Publication Details: Journal of Antimicrobial Chemotherapy, Vol.74(12), pp.3639-3641
Publisher: Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy
Identifiers: 991005542050507891
Copyright: © 2020 Oxford University Press
Murdoch Affiliation: Antimicrobial Resistance and Infectious Disease Laboratory; School of Veterinary and Life Sciences
Language: English
Resource Type: Journal article

This output has contributed to the advancement of the following goals:

Source: InCites

58 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.23 Antibiotics & Antimicrobials; 1.23.173 MRSA and VRE
Web Of Science research areas: Infectious Diseases; Microbiology; Pharmacology & Pharmacy
ESI research areas: Pharmacology & Toxicology